Angiotech Pharmaceuticals

Contact
angiotech.com
+1604221-7676

Angiotech Pharmaceuticals, Inc.

1618 Station Street
V6A 1B6 Vancouver
Canada
+1604221-7676
angiotech.com
Contact
Profile News
Contact

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury.

Read more about Angiotech Pharmaceuticals
Facts about Angiotech Pharmaceuticals
  • Focus : Manufacturer
  • Industry : Pharma

News about Angiotech Pharmaceuticals

Angiotech Pharmaceuticals

18-Oct-2013 | people

Angiotech Announces Changes to Management and Board of Directors

Angiotech Pharmaceuticals, Inc.  announced that its shareholders and Board of Directors have approved changes to the Company's executive management team ...

Read news
Angiotech Pharmaceuticals

27-Sep-2010 | research and development

Angiotech Pharmaceuticals and Athersys announce results from phase I study of Multistem in heart attack patients

Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced updated results from its phase I clinical trial of MultiStem(R), its allogeneic cell ...

Read news
Angiotech Pharmaceuticals

12-Mar-2009 | research and development

Angiotech announces positive results from Bio-Seal(TM) clinical study

Angiotech Pharmaceuticals, Inc. announced positive clinical study results for its Bio-Seal(TM) Lung Biopsy Tract Plug System at the Society of Interventiona ...

Read news
Angiotech Pharmaceuticals

17-Apr-2008 | people

Angiotech announces director resignation

Angiotech Pharmaceuticals, Inc. announced the resignation of Greg Peet from his position as a non-executive director of the Company. Mr. Peet has resigned ...

Read news
Angiotech Pharmaceuticals

19-Mar-2007 | research and development

Angiotech receives favourable decision from the European Patent Office EPO

Angiotech Pharmaceuticals, Inc. announced a favourable decision regarding its Hunter Patent from the European Patent Office (EPO) in Munich, Germany. The E ...

Read news
Angiotech Pharmaceuticals

29-May-2006 | business & finance

Angiotech Pharmaceuticals to acquire Quill Medical Inc.

Angiotech Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to acquire privately held Quill Medical, Inc., a provider of ...

Read news
Angiotech Pharmaceuticals

11-May-2006 | business & finance

Angiotech Pharmaceuticals and Genzyme Corporation Form Collaboration to Develop Innovative Surgical Oncology Treatments

Angiotech Pharmaceuticals, Inc. and Genzyme Corporation announced that they have entered into a strategic collaboration agreement designed to identify, ...

Read news
Angiotech Pharmaceuticals

05-May-2006 | politics & laws

Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands

Boston Scientific Corporation and Angiotech Pharmaceuticals, Inc. announced that they received a favorable decision from a Dutch court in a patent dispute ...

Read news
Show more news about Angiotech Pharmaceuticals

Here you will find Angiotech Pharmaceuticals, Inc.